Rizzuto Debora, Melis René J F, Angleman Sara, Qiu Chengxuan, Marengoni Alessandra
Department of Neurobiology, Health Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Department of Geriatric Medicine, Nijmegen Alzheimer Centre, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
J Am Geriatr Soc. 2017 May;65(5):1056-1060. doi: 10.1111/jgs.14868. Epub 2017 Mar 17.
To determine the effect of chronic disorders and their co-occurrence on survival and functioning in community-dwelling older adults.
Population-based cohort study.
Kungsholmen, Stockholm, Sweden.
Individuals aged 78 and older examined by physicians four times over 11 years (N = 1,099).
Chronic diseases (grouped according to 10 organ systems according to the International Classification of Diseases, Tenth Revision, code) and multimorbidity (≥2 coexisting chronic diseases) were evaluated in terms of mortality, population attributable risk of death, median years of life lost, and median survival time with and without disability (need of assistance in ≥1 activities of daily living).
Approximately one in four deaths were attributable to cardiovascular and one in six to neuropsychiatric diseases. Malignancy was the condition with the shortest survival time (2.5 years). Malignancies and cardiovascular disorders each accounted for approximately 5 years of life lost. In contrast, neurosensorial and neuropsychiatric conditions had the longest median survival time (>6 years), and affected people were disabled for more than half of this time. The most-prevalent and -burdensome condition was multimorbidity, affecting 70.4% of the population, accounting for 69.3% of total deaths, and causing 7.5 years of life lost. Finally, people with multimorbidity lived 81% of their remaining years of life with disability (median 5.2 years).
Survival in older adults differs in length and quality depending on specific conditions. The greatest negative effect at the individual (shorter life, greater dependence) and societal (number of attributable deaths, years spent with disability) level was from multimorbidity, which has made multimorbidity a clinical and public health priority.
确定慢性疾病及其共病情况对社区居住的老年人的生存和功能的影响。
基于人群的队列研究。
瑞典斯德哥尔摩的 Kungsholmen。
年龄在 78 岁及以上的个体,在 11 年中接受医生 4 次检查(N = 1099)。
根据国际疾病分类第十版编码,按照 10 个器官系统对慢性疾病进行分组,并评估共病(≥2 种并存的慢性疾病)对死亡率、人群归因死亡风险、中位寿命损失年数以及有无残疾(日常生活中≥1 项活动需要协助)时的中位生存时间的影响。
约四分之一的死亡归因于心血管疾病,六分之一归因于神经精神疾病。恶性肿瘤是生存时间最短的疾病(2.5 年)。恶性肿瘤和心血管疾病各自导致约 5 年的寿命损失。相比之下,神经感觉和神经精神疾病的中位生存时间最长(>6 年),且受影响的人在超过一半的时间里处于残疾状态。最普遍且负担最重的情况是共病,影响了 70.4%的人群,占总死亡人数的 69.3%,并导致 7.5 年的寿命损失。最后,患有共病的人在其剩余寿命中有 81%的时间处于残疾状态(中位时间为 5.2 年)。
老年人的生存长度和质量因特定疾病而异。共病在个体(寿命缩短、依赖性增强)和社会(归因死亡人数、残疾时间)层面产生的负面影响最大,这使得共病成为临床和公共卫生的重点。